Medtronic MiniMed, Inc.
Clinical trials sponsored by Medtronic MiniMed, Inc., explained in plain language.
Makes insulin pumps and diabetes management devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Implantable pump could ease diabetes management for 40 patients Results expected Dec 2026 (estimated)
- New insulin pump system put to the test in 400-Person safety trial Results expected Jan 2027 (estimated)
- New insulin pump system aims to improve diabetes management Results expected Mar 2027 (estimated)
-
Smart insulin pump helps type 2 diabetes patients control blood sugar at home
Disease control CompletedThis study tested the safety and effectiveness of the MiniMed 780G automated insulin pump in 574 adults with type 2 diabetes who need insulin. Participants used the system at home for about 135 days. The goal was to see if the pump improved blood sugar control without causing saf…
Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Smart pen and sensor combo aims to simplify diabetes management
Disease control CompletedThis study tested a smart system that combines a Bluetooth-enabled insulin pen with a continuous glucose monitor to help people with type 1 diabetes manage their blood sugar. 179 participants used either the smart system or standard insulin injections and glucose monitoring for 6…
Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New insulin pump system tested for safety in toddlers and preschoolers with diabetes
Disease control CompletedThis study looked at whether the MiniMed 780G insulin pump, when used with a continuous glucose monitor, is safe for children aged 2 to 6 years with type 1 diabetes. Fifty-six children used the system at home. The main goals were to measure how often their blood sugar stayed in a…
Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Will a sticky patch stay put? study tests future pump design on kids
Knowledge-focused CompletedThis study tests how well the adhesive parts of a future patch pump stick to the skin of children aged 7 to 17 who need insulin for diabetes. The device is a dummy—it has no electronics and just mimics the shape and weight of a real pump. Researchers will see if the patch stays a…
Sponsor: Medtronic MiniMed, Inc. • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Sticky test: will this patch pump stay put for a week?
Knowledge-focused CompletedThis study tests how well a dummy patch pump (with no electronics or medicine) sticks to the skin of 175 adults with insulin-requiring diabetes. The goal is to see if the adhesive can stay on for 5 to 7 days in different body locations. The results will help design a future comme…
Sponsor: Medtronic MiniMed, Inc. • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC